Researchers conducted a study to characterize ophthalmic adverse events associated with cosmetics and personal care products ...

EyePoint (EYPT) stock rose 10% after the company reported six-month results from a phase 2 study of its drug Duravyu in the treatment of diabetic macular edema. Read more here.

Genentech Inc. won regulatory approval Tuesday to market an eye implant that can be refilled every six months with an already ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug ...

Sales of Eylea, which the company co-developed with Bayer (DE:BAYA), rose 2% to $1.495 billion. Sales of the higher-dose, longer-lasting formulation Eylea HD rose 148% to $305 million in the U.S., ...

It was there that Mr Pearce, 40, was diagnosed with a branch retinal vein occlusion, where one of the veins in the retina ...

15, 2025 — Data from continuous glucose monitors can predict nerve, eye and kidney damage caused by type 1 diabetes researchers have found. That suggests doctors may be able to use data from the ...

They also will evaluate advances in imaging and current and emerging therapies for the treatment and management of retinal vein occlusion. Upon successful completion of this educational activity ...

Three players in the biosimilar space have already sparked hope for the new year, with each having big business or regulatory ...

To avoid disaster, the Government has limits for legal and illegal drugs, so ask your doctor if you’re unsure. But it’s not ...

At a single academic tertiary referral center, mild intraocular inflammation developed in four eyes following intravitreal ...

This is a demo project that incorporates 3D passive face liveness detection, face recognition, face capture, and analysis of face attributes including age, gender, face quality, face occlusion, eye ...